Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Melanoma gp100 antibody

The Mouse Monoclonal anti-Melanoma gp100 antibody is suitable to detect Melanoma gp100 in samples from Human and Dog. It has been validated for IHC and WB.
Catalog No. ABIN2725799
$608.40
Plus shipping costs $50.00
0.1 mL
Shipping to: United States
Delivery in 6 to 9 Business Days

Quick Overview for Melanoma gp100 antibody (ABIN2725799)

Target

See all Melanoma gp100 (PMEL) Antibodies
Melanoma gp100 (PMEL) (Premelanosome Protein (PMEL))

Reactivity

  • 125
  • 13
  • 12
  • 11
  • 7
  • 2
  • 1
  • 1
  • 1
  • 1
Human, Dog

Host

  • 69
  • 53
  • 4
  • 1
Mouse

Clonality

  • 76
  • 48
  • 2
Monoclonal

Conjugate

  • 55
  • 10
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
This Melanoma gp100 antibody is un-conjugated

Application

  • 67
  • 66
  • 42
  • 41
  • 25
  • 20
  • 14
  • 7
  • 5
  • 5
  • 3
  • 2
  • 1
  • 1
  • 1
Immunohistochemistry (IHC), Western Blotting (WB)

Clone

9G3
  • Purification

    Purified from mouse ascites fluids by affinity chromatography

    Immunogen

    Full-length protein expressed in 293T cell transfected with human SILV expression vector

    Isotype

    IgG1
  • Application Notes

    WB 1:2000, IHC: 1:150

    Comment

    The concentration of the product may vary between diferrent lots.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    0.5-1.0 mg/mL

    Buffer

    PBS ( pH 7.3) containing 1 % BSA, 50 % glycerol and 0.02 % sodium azide.

    Preservative

    Sodium azide

    Precaution of Use

    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
  • Target

    Melanoma gp100 (PMEL) (Premelanosome Protein (PMEL))

    Alternative Name

    SILV

    Molecular Weight

    70.3 kDa

    Gene ID

    6490

    NCBI Accession

    NM_006928

    HGNC

    6490
You are here:
Chat with us!